Also, VEGF silencing resulted in enhanced cytotoxicity of the chemotherapeutic agent 5-fluorouracil suggesting the promise of this strategy to be employed as an adjuvant therapy against lung cancer. This evidence concerns the gene VEGFA and lung cancer.